1/21
Vocabulary flashcards covering the taxonomy, transmission cycles, morphologies, clinical manifestations, diagnosis, and pathology of Toxoplasma gondii and related parasitic protozoa.

Protozoa (Major Groups)
A diverse group of unicellular eukaryotes categorized into four main morphological groups: Amoebas (using pseudopods), Flagellates (using flagella), Ciliates (using cilia), and Apicomplexans/Sporozoa (intracellular, non-motile parasites).
Apicomplexa (Sporozoa)
A group of non-motile, usually intracellular protozoan parasites that undergo complex life cycles involving both asexual and sexual reproduction stages (e.g., Plasmodium, Babesia, and Toxoplasma gondii).
Toxoplasma gondii
An intracellular protozoan parasite of the Sporozoa group causing foodborne, systemic zoonotic infections worldwide characterized by chronic-latent persistence without causing enteric disease or direct human fecal-oral transmission.
Heteroxenous Parasite
A parasite that requires more than one host species to complete its full life cycle, cycling between definitive hosts and intermediate hosts.
Definitive Host (Toxoplasma gondii)
Felids (cats), in which sexual reproduction occurs in the intestinal epithelium, culminating in the shedding of unsporulated oocysts in feces.
Dead-End Host
An intermediate host, such as a human, that harbors tissue cysts but does not typically transmit the parasite onward via the natural prey-predator cycle.
Tachyzoite
The rapidly dividing, motile vegetative stage of Toxoplasma gondii that actively invades host nucleated cells during acute infection and crosses biological barriers such as the placenta.
Bradyzoite
The slowly multiplying, quiescent stage of Toxoplasma gondii that persists lifelong inside intracellular tissue cysts within neurons, skeletal muscle, and myocardium.

Tissue Cyst (Toxoplasma gondii)
The intracellular resistance and latent structure formed in brain and muscle cells containing hundreds of bradyzoites, maintained under control by Th1 cell-mediated immunity.
Oocyst
The environmental resistance form of Toxoplasma gondii passed unsporulated in cat feces, which sporulates in the outside environment and infects hosts via contaminated fresh water, fruits, or vegetables.

Transmission Pathways of Toxoplasma gondii
Human transmission occurs primarily via ingestion of tissue cysts in raw or undercooked meat (pork, goat, sheep), ingestion of sporulated oocysts from contaminated water/soil/produce, transplacental transmission of tachyzoites to the fetus, or blood transfusions and organ transplants.
Global Seroprevalence of Toxoplasmosis
The worldwide average seroprevalence rate of Toxoplasma gondii antibodies in humans is approximately 31%, ranging regionally from 0.5% to 88%.
Recrudescence (Toxoplasmosis)
The reactivation of a quiescent Toxoplasma gondii infection in immunocompromised hosts (e.g., HIV+ patients), where bradyzoites escape tissue cysts, convert into destructive tachyzoites, and cause necrotic brain abscesses or myocarditis.
Predator Aversion Loss (Parasite Mind Control)
A behavioral alteration in Toxoplasma-infected rodents where cyst accumulation in cortical areas and neuroinflammation drive an increase in dopamine secretion, eliminating innate feline fear.
Congenital Toxoplasmosis
Infection passed vertically from mother to fetus occurring exclusively when a pregnant woman acquires an acute primary Toxoplasma gondii infection during gestation.
Trimester Severity vs. Transmission Rule (Toxoplasmosis)
Vertical transmission risk increases by gestational age (15% in 1st trimester, 30% in 2nd, 60% in 3rd), whereas clinical severity is inverse, showing highest sequelae (+++) in the 1st trimester and lowest immediate damage ($$+$) in the 3rd trimester.
Clinical Triad & Signs of Congenital Toxoplasmosis
Major developmental sequelae including hydrocephalus, intracranial calcifications, chorioretinitis, convulsions, mental retardation, hepatosplenomegaly, jaundice, and spontaneous abortion.
Chorioretinitis
Inflammation and necrotic scarring of the retina and choroid caused by Toxoplasma gondii, presenting as ocular lesions in congenital disease or reactivated immunocompromised states.

Indirect Diagnosis of Toxoplasmosis
The gold-standard method for immunocompetent individuals based on the detection and kinetic monitoring of serum-specific IgM and IgG antibodies.
Direct Diagnosis of Toxoplasmosis
Demonstration of the parasite by microscopic histology or detection of Toxoplasma DNA using high-sensitivity PCR in amniotic fluid, neonatal blood, or tissue biopsies.
TOXO-test
Serological screening profile in pregnant women where IgG+/IgM− indicates pre-existing immunity/protection, IgG−/IgM− indicates susceptibility, and IgM+ signals potential acute infection and transmission risk.
Medical Management of Gestational Toxoplasmosis
Administration of spiramycin or combination therapy with pyrimethamine and sulfadiazine to infected pregnant mothers, followed by neurological and ocular surveillance of the infant throughout the first year of life.